Trump Administration Issues Drug Price Transparency Proposed Rule

Provided By:

Manatt Health

October 25, 2018

On October 15, the Trump Administration published a proposed rule that, if finalized, would require prescription drug makers to include drug price information in broadcast advertising. This controversial proposal would implement an idea first broached in the Administration’s drug pricing Blueprint.

Learn more about the proposed rule in this white paper using the link below.

Also hear the related podcast using the link below.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK